SEC Comment Letter 0000000000-24-003014 to MUSTANG BIO, INC. (MBIO) (CIK 0001680048) (MBIO)
MUSTANG BIO, INC. (MBIO) (CIK 0001680048)
Date: March 20, 2024 · CIK: 0001680048 · Accession: 0000000000-24-003014
AI Filing Summary & Sentiment
File numbers found in text: 333-278006
Letter
United States securities and exchange commission logo March 20, 2024 James Murphy Interim Chief Financial Officer Mustang Bio, Inc. 377 Plantation Street Worcester, Massachusetts 01605 Re:Mustang Bio, Inc. Registration Statement on Form S-1 Filed March 15, 2024 File No. 333-278006 Dear James Murphy: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jimmy McNamara at 202-551-7349 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences
Show Raw Text
United States securities and exchange commission logo
March 20, 2024
James Murphy
Interim Chief Financial Officer
Mustang Bio, Inc.
377 Plantation Street
Worcester, Massachusetts 01605
Re:Mustang Bio, Inc.
Registration Statement on Form S-1
Filed March 15, 2024
File No. 333-278006
Dear James Murphy:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jimmy McNamara at 202-551-7349 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences